ZTS Q4 2019 Earnings — Zoetis Inc. Revenue & Financial Results | Market Cap Arena

ZTSZoetis Inc.

$52B

Q4 2019 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$1.7B+7.0% YoY

Gross Profit

$1.1B65.9% margin

Operating Income

$500M29.9% margin

Net Income

$384M22.9% margin

EPS (Diluted)

$0.80

QoQ Revenue Growth

+5.7%

Cash Flow

Operating Cash Flow

$582M

Free Cash Flow

$416M

Stock-Based Comp.

$16M

Balance Sheet

Total Assets

$11.5B

Total Liabilities

$8.8B

Stockholders' Equity

$2.7B

Cash & Equivalents

$1.9B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.7B	$1.6B	+7.0%
Gross Profit	$1.1B	$981M	+12.5%
Operating Income	$500M	$436M	+14.7%
Net Income	$384M	$345M	+11.3%

Revenue Segments

Horses

$2.1B58%

Cattle

$885M24%

Swine

$320M9%

Poultry

$285M8%

Fish

$69M2%